Dexcom Inc DRC (D1EX34)

Currency in BRL
8.77
-0.28(-3.09%)
Closed·
D1EX34 Scorecard
Full Analysis
Management has been aggressively buying back shares
D1EX34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.779.00
52 wk Range
6.7110.59
Key Statistics
Bid/Ask
8.69 / 9.84
Prev. Close
9.05
Open
9
Day's Range
8.77-9
52 wk Range
6.71-10.59
Volume
135
Average Volume (3m)
133
1-Year Change
8.41%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
D1EX34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
11 analysts have revised their earnings upwards for the upcoming period

Dexcom Inc DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Dexcom Inc DRC Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Employees
10250
Market
Brazil

Compare D1EX34 to Peers and Sector

Metrics to compare
D1EX34
Peers
Sector
Relationship
P/E Ratio
54.4x−3.8x−0.5x
PEG Ratio
−4.77−0.270.00
Price/Book
12.1x2.8x2.6x
Price / LTM Sales
7.2x3.1x3.2x
Upside (Analyst Target)
-36.2%45.7%
Fair Value Upside
Unlock6.2%8.6%Unlock

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
0.45 / --
Revenue / Forecast
1.16B / --
EPS Revisions
Last 90 days

D1EX34 Income Statement

FAQ

What Stock Exchange Does Dexcom DRC Trade On?

Dexcom DRC is listed and trades on the B3 Stock Exchange stock exchange.

What Is the Stock Symbol for Dexcom DRC?

The stock symbol for Dexcom DRC is "D1EX34."

What Is the Dexcom DRC Market Cap?

As of today, Dexcom DRC market cap is 172.30B.

What Is Dexcom DRC's Earnings Per Share (TTM)?

The Dexcom DRC EPS (TTM) is 1.46.

From a Technical Analysis Perspective, Is D1EX34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Dexcom DRC Stock Split?

Dexcom DRC has split 1 times.

How Many Employees Does Dexcom DRC Have?

Dexcom DRC has 10250 employees.

What is the current trading status of Dexcom DRC (D1EX34)?

As of 02 Aug 2025, Dexcom DRC (D1EX34) is trading at a price of 8.77, with a previous close of 9.05. The stock has fluctuated within a day range of 8.77 to 9.00, while its 52-week range spans from 6.71 to 10.59.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.